Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS
Interview with Michael Maglin, CEO of CraniUS
CraniUS obtains scientific evidence of successful convection-enhanced delivery using patented NeuroPASS device
CraniUS Announces a Strategic Partnership with Leading Drug and Device Manufacturer, Medical Product Laboratories
CraniUS Appoints Industry-Leading Executive in MedTech Space to serve as Vice-Chair on Board of Directors
CraniUS Closes ~$20 Million Series A Funding Round
The NeuroPASS device is currently in the pre-clinical development stage and is not yet commercially available. It is on the pathway to clinical studies, and any information provided is subject to change as research progresses.
CAUTION: Investigational Device. Limited by Federal (or United States) law to investigational use.
© Copyright 2025 | CraniUS
